evaluate the pharmaceuticals company mounjaro on glp-1 and insurance providers Medications Show Promise as First Drug Therapy for Sleep Apnea January 2026: New or Expanded

2023;10 doi: 10.3389/fmolb.2023.1210347

I would not recommend microdosing GLP-1s for individuals with significant amounts of weight to lose or known metabolic dysregulation. The bottom line is that there are still questions regarding the effectiveness and safety of microdosing GLP-1 medications, and this type of regimen is not for everyone

Comparator Selection : Many trials use placebo comparisons rather than active comparators, limiting understanding of relative effectiveness compared to existing obesity treatments

[2] LINONG JI, HONGWEI JIANG, HUA LI, JUNHANG TIAN, DEXUE LIU, YUZHU ZHAO, JIEYU GU, ZIHAN LIU, HUAN DENG, YANQI WANG, LI LI, LEI QIAN, THE GLORY-1 INVESTIGATORS

Irving P, Barrett K, Nijher M, de Lusignan S